Changjing Zuo
- Biomedical Engineering top 5%
- Materials Chemistry top 10%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Surgery top 10%
- Topics
- Peptidase Inhibition and Analysis (23 papers)Pancreatic and Hepatic Oncology Research (22 papers)Radiomics and Machine Learning in Medical Imaging (17 papers)
- Partner nations
- ChinaUnited StatesTanzania
In The Last Decade
Changjing Zuo
129 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biomedical Engineering 845
- Materials Chemistry 570
- Pulmonary and Respiratory Medicine 485
- Oncology 457
- Surgery 399
Countries citing papers authored by Changjing Zuo
This map shows the geographic impact of Changjing Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjing Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjing Zuo more than expected).
Fields of papers citing papers by Changjing Zuo
This network shows the impact of papers produced by Changjing Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjing Zuo. The network helps show where Changjing Zuo may publish in the future.
Co-authorship network of co-authors of Changjing Zuo
This figure shows the co-authorship network connecting the top 25 collaborators of Changjing Zuo. A scholar is included among the top collaborators of Changjing Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjing Zuo. Changjing Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 7 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 10 | |
| 10 | 3 | |
| 11 | 9 | |
| 12 | 34 | |
| 13 | 36 | |
| 14 | 44 | |
| 15 | 2 | |
| 16 | 9 | |
| 17 | 17 | |
| 18 | Hypoxia Induced by Upconversion‐Based Photodynamic Therapy: Towards Highly Effective Synergistic Bioreductive Therapy in Tumorsbreakdown → | 404 |
| 19 | 13 | |
| 20 | 29 |
About Changjing Zuo
Changjing Zuo is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 137 papers that have together received 2.1k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (23 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Radiomics and Machine Learning in Medical Imaging (17 papers). The work is most often cited by research in Cancer Research (314 citations), Biomedical Engineering (845 citations) and Oncology (457 citations). Changjing Zuo has collaborated with scholars based in China, United States and Tanzania. Frequent co-authors include Chao Cheng, Wenbo Bu, Dalong Ni, Jianlin Shi, Chen Zhang, Aisheng Dong, Qingfeng Xiao, Yanyan Liu, Jianan Liu and Yong Sun. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.